Rating Change
Barclays reiterated its Underweight rating on Aspen Aerogels, Inc. (NYSE:ASPN) on August 11, 2026.
Barclays reiterated its Underweight rating on Aspen Aerogels, Inc. (NYSE:ASPN) on August 11, 2026.

At publication ·
Aspen Aerogels, Inc. (NYSE:ASPN) · reiterate
At a glance
Barclays reiterated its Underweight rating on Aspen Aerogels, Inc. (NYSE:ASPN) on August 11, 2026.
Aspen Aerogels, Inc. operates in the Industrials sector. The stock currently trades at $6.12 with a market capitalization of $257.9M.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Aspen Aerogels, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 4 Buy, 1 Hold, 5 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 11, 2026 | Barclays | Underweight | N/A |
| May 11, 2026 | Barclays | Underweight | N/A |
| Mar 05, 2026 | Barclays | Underweight | N/A |
| Feb 26, 2026 | Roth Capital | Buy | N/A |
| Feb 26, 2026 | TD Cowen | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ASPN Stock Page
A rating of Underweight from Barclays reflects the analyst's outlook on Aspen Aerogels, Inc. (NYSE:ASPN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ASPN forecast page.
Current market data
NYSE · ASPN
$4.91
Up: +$0.15 · +3.15%
Live quote updated
Keep reading